The emerging bioprocess automation software market offers opportunities in enhancing biomanufacturing efficiency and consistency through digitalization. Demand is bolstered by the need for real-time ...

Key opportunities in the bioprocessing market include expansion in downstream processing, cell and gene therapies, and ...

Researchers based in Sweden have developed a metabolism-based model of mammalian cell types commonly used in antibody production. The team, led by Veronique Chotteau, PhD, a professor at KTH Royal ...

According to Nova One Advisor, the U.S. single-use bioprocessing market size was estimated at USD 9.65 billion in 2024 and is projected to grow to USD 39.24 billion by 2034, rising at a compound ...

The AI-optimized BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform combines the skills of CPI (UK), Basetwo (Canada), Nicoya (Canada), and Labman ...

According to Nova One Advisor, the global single-use bioprocessing market size is expected to be worth around 151.48 billion by 2034, increasing from USD 39.01 billion in 2025, representing a healthy ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

Today’s common bioprocessing technologies do not efficiently develop complex biologics like cell and gene therapy and mRNA products. The at-line monitoring, off-line analytics, and legacy control ...

GARDENA, Calif.--(BUSINESS WIRE)--Spectrum Chemical Mfg. Corp., a leading global provider of fine chemicals, laboratory equipment and supplies, announced today it has added 12 new products to its ...